Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis

BackgroundEvidence regarding the mortality benefit of implantable cardioverter defibrillator (ICD) non-ischemic dilated cardiomyopathy (NIDCM) is inconsistent. The most recent randomized study, the DANISH trial, did not find improved outcomes with ICD. However, based on previous studies and meta-ana...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yotam Kolben, Bruria Hirsh Raccah, Ivelin Koev, David Luria, Offer Amir, Yitschak Biton
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-05-01
Serie:	Frontiers in Cardiovascular Medicine
Soggetti:	ICD (implantable cardioverter-defibrillator) NIDCM SGLT 2 inhibitors ARNI angiotensin receptor neprilysin inhibitor sudden cardiac death (SCD)
Accesso online:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1192101/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!